• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    S&P Biotech SPDR (NY: XBI )

    79.32 -1.20 (-1.49%)
    Official Closing Price Updated: 8:00 PM EST, Dec 8, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 9,324,834
    Open 80.21
    Bid (Size) 79.33 (6)
    Ask (Size) 79.48 (1)
    Prev. Close 80.52
    Today's Range 79.22 - 81.13
    52wk Range 63.80 - 92.60
    Shares Outstanding 807,500
    Dividend Yield 0.00%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Can Small Cap Biotech Stocks Continue To Run? Let’s Take A Look
    Over the past 4 weeks, we have seen a nice run in small-cap, speculative biotech stocks. This coincided with the pause in interest rates and expectations of the seasonal year-end rally. 
    Via Talk Markets
    Fed Rate Cut Speculations Rattle Stocks, Commodities Slide, Bitcoin Shines: What's Driving Markets Monday?
    Stocks opened the first week of December with significant losses, driven by some emerging concerns of exaggerated rate cut speculations within the trading community. 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates

    Performance

    YTD
    -2.71%
    -2.71%
    1 Month
    +14.24%
    +14.24%
    3 Month
    +0.85%
    +0.85%
    6 Month
    -11.07%
    -11.07%
    1 Year
    -2.77%
    -2.77%

    More News

    Read More
    Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday?
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    S&P 500, Nasdaq Slip As Tech Underperforms, Oil Reacts to OPEC+: What's Driving Markets Thursday?
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Stocks Drift Higher On Stronger GDP Data, Oil Rebounds As OPEC+ Mulls Cuts: What's Driving Markets Wednesday?
    Via Benzinga
    US Stocks Rebound As Treasury Yields, Dollar Fall On Dovish Fed Remarks, Gold Hits $2,040: What's Driving Markets Tuesday?
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Biotech And Healthcare Portfolio Playbook For December 2023/24
    Via Talk Markets
    Are You A Trader Or Investor: Biotech Momentum Is Picking Up
    Via Talk Markets
    Topics ETFs
    3 Biotech Stocks That Could Boom or Bust by 2025
    Via InvestorPlace
    Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
    Via Talk Markets
    Exposures COVID-19
    This Week’s Data Dump May Lead To More Stock Market Pain
    Via Talk Markets
    It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy
    Via The Motley Fool
    Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
    Via Talk Markets
    Topics Economy
    Exposures Economy
    Thoughts For Thursday: War Worries Rattle The Market
    Via Talk Markets
    Too Much To Handle For Stocks As Rates Continue To Rise
    Via Talk Markets
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Stocks and Bonds Go Their Separate Ways
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up
    Via Talk Markets
    Stocks Rally And Rates Drop But Trends Remain In Place
    Via Talk Markets
    Don’t Miss the Boom: 3 ETFs Set to Explode Higher
    Via InvestorPlace
    Topics ETFs
    Healthcare Playbook Revisited - Growth Plus Value
    Via Talk Markets
    Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
    Via InvestorPlace
    EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
    Via Benzinga
    Healthcare Portfolio: A Mixed Market Looking for Value
    Via Talk Markets
    Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio?
    Via Talk Markets
    Topics ETFs
    Exposures COVID-19
    If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.